Schott Pharma & CO. (1SXP.F) Q4 2024 Earnings

12DecConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
0.17
0.21
0.25
0.3

Details

Expected EPS
0.259365763774836
Actual EPS
0.24445807277999998
Surprise EPS
-0.01
Surprise Percent
+5.75%

Description

Schott Pharma & CO. (1SXP.F) has reported earnings of 0.24445807277999998 per share for Q4 2024.

0 Comments

Share your thoughts